FEDERATED HERMES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 82 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$845
+0.6%
1700.0%0.00%
Q1 2023$840
-100.0%
170
-99.9%
0.00%
-100.0%
Q4 2022$1,722,535
+172153.5%
273,853
+636767.4%
0.01%
Q3 2022$1,0000.0%430.0%0.00%
Q2 2022$1,000
-99.8%
43
-99.9%
0.00%
-100.0%
Q1 2022$535,000
+32.1%
58,693
+265.8%
0.00%0.0%
Q4 2020$405,000
-87.2%
16,044
-80.9%
0.00%
-85.7%
Q3 2020$3,171,000
-37.1%
84,088
-28.6%
0.01%
-41.7%
Q2 2020$5,040,000
-0.4%
117,707
-32.7%
0.01%
-7.7%
Q1 2019$5,059,000
+7.3%
175,0000.0%0.01%0.0%
Q4 2018$4,713,000175,0000.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders